Sepsis

SEP 9, 2026 · OBSERVATIONAL STUDY

PICS: Subtitle Cardiac Dysfunction in Older Sepsis Survivors

ClinicalTrials.gov

This is an active observational registry record with no reported results; it describes an ongoing study designed to characterize biomarkers and outcomes in sepsis survivors.

SEP 9, 2026 · PHASE 3 TRIAL

Early Empiric Anti-Mycobacterium Tuberculosis Therapy for Sepsis in Sub-Saharan Africa

ClinicalTrials.gov

Phase 3 RCT with completed recruitment (437 participants) addressing a significant clinical question, but this registry record reports no results; evidence strength cannot be assessed without outcome data.

SEP 8, 2026 · OBSERVATIONAL STUDY

Evaluation of Jugular Venous Distensibility Index in Intravascular Fluid Management and Comparison of the Effectiveness of Noninvasive and Minimally Invasive Methods

ClinicalTrials.gov

This is a completed observational registry record with no posted results; it describes a planned diagnostic correlation study in 82 critically ill patients but reports no outcomes, effect sizes, or conclusions.

SEP 4, 2026 · INTERVENTIONAL STUDY

Hospital-Onset Sepsis Systematic Detection and Structured Interventions

ClinicalTrials.gov

This is a registry record for a planned interventional study with no results reported; enrollment is not yet active, making it a feasibility and design description only.

SEP 2, 2026 · PHASE 2 TRIAL

A Study to Investigate the Efficacy, Safety, and Tolerability of AZD4144in Participants With Sepsis-associated Acute Kidney Injury.

ClinicalTrials.gov

Phase 2 interventional trial in a serious acute condition with surrogate renal endpoint; results not yet reported in this registry record.

SEP 1, 2026 · OBSERVATIONAL STUDY

Plasma Neprilysin for Predicting Sepsis Within 48 Hours in ICU Patients With Infection or Suspected Infection

ClinicalTrials.gov

This is an ongoing observational registry study with no results reported; it is designed to explore whether plasma neprilysin predicts sepsis development within 48 hours in ICU patients.

SEP 1, 2026 · PHASE 2 TRIAL

Senolytics To slOw Progression of Sepsis (STOP-Sepsis) Trial

ClinicalTrials.gov

This is a Phase 2 adaptive allocation trial in active recruitment with no results posted; it is designed to identify an efficacious dose and predict Phase 3 success, not to establish clinical benefit.

SEP 1, 2026 · OBSERVATIONAL STUDY

Extended vs. Intermittent Meropenem Infusion in Sepsis Patients in the ICU

ClinicalTrials.gov

This is a registry record for a planned observational study with no reported results; enrollment has not yet begun, making it an early-stage descriptive protocol.